Nasal immunization of nonhuman primates with simian immunodeficiency virus p55(gag) and cholera toxin adjuvant induces Th1/Th2 help for virus- specific immune responses in reproductive tissues

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 5952-5958

  Imaoka, Koichi ^a,b   Miller, Christopher J ^c   Kubota, Mitsuru ^a   McChesney, Michael B ^c   Lohman, Barbara ^c   Yamamoto, Masafumi ^a,e   Fujihashi, Kohtaro ^a   Someya, Kenji ^d   Honda, Mitsuo ^d   McGhee, Jerry R ^a   Kiyono, Hiroshi ^a,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL ISOLATION; DEVELOPING COUNTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; MUCOSAL IMMUNITY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CHOLERA TOXIN; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE PRODUCTS, GAG; MACACA MULATTA; NASAL MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; VAGINA;

EID: 0032402228     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Quinn, T. C. 1996. Global burden of the HIV pandemic. Lancet 348:99.
2. Kiyono, H., C. J. Miller, Y. Lu, T. Lehner, M. Cranage, Y. T. Huang, S. Kawabata, M. Marthas, B. Roberts, J. G. Nedrud, M. E. Lamm, L. Bergmeier, R. Brookes, L. Tao, and J. R. McGhee. 1995. The common mucosal immune system for the reproductive tract: basic principles applied toward an AIDS vaccine. Adv. Drug Delivery Rev. 18:23.
3. Miller, C. J., J. R. McGhee, and M. B. Gardner. 1993. Mucosal immunity, HIV transmission, and AIDS. Lab. Invest. 68:129.
4. Graham, B. S., and P. F. Wright. 1995. Candidate AIDS vaccines. N. Engl. J. Med. 333:1331.
5. Lehner, T., and C. J. Miller. 1996. Rectal and genital immunization with SIV/ HIV. In Mucosal Vaccines. H. Kiyono, P. L. Ogra, and J. R. McGhee, eds. Acdemic Press, San Diego, p. 357.
6. Staats, H. F., and J. R. McGhee. 1996. Application of basic principles of mucosal immunity to vaccine development. In Mucosal Vaccines. H. Kiyono, P. L. Ogra, and J. R. McGhee, eds. Academic Press, San Diego, p. 17.
7. Berzofsky, J. A., and I. J. Berkower. 1995. Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: advances in 1994-1995. AIDS 9:S143.
8. Miller, C. J., N. J. Alexeander, S. Sutjipto, A. A. Lackner, A. Gettie, A. G. Hendrickx, L. J. Lowenstine, M. Jennings, and P. A. Marx. 1989. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63:4277.
9. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamschikov, D. Chen, and J. H. Eldrigde. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323.
10. Lehner, T., Y. Wang, M. Cranage, L. A. Bergmeier, E. Mitchell, L. Tao, G. Hall, M. Dennis, N. Cook, R. Brookes, L. S. Klavinskis, I. Jones, C. Doyle, and R. G. Ward. 1996. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:767.
11. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
12. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J. R. McGhee. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621.
13. Kubota, M., C. J. Miller, K. Imaoka, S. Kawabata, K. Fujihashi, J. R. McGhee, and H. Kiyono. 1997. Oral immunization with simian immunodeficiency virus (SIV) p55 gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in non-human primates. J. Immunol. 158:5321.
14. Staats, H. F., W. G. Nichols, and T. J. Palker. 1996. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after nasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:462.
15. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, M. Yamamoto, K. Fujihashi, F. W. van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee. 1997. A non-toxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267.
16. Elson, C. O. 1996. Cholera toxin as a mucosal adjuvant. In Mucosal Vaccines. H. Kiyono, P. L. Ogra, and J. R. McGhee, eds. Academic Press, San Diego, p. 357.
17. Yamamoto, S., Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, M. Yamamoto, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee. 1997. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrhoeagenecity but retain adjuvanticity. J. Exp. Med. 185:1203.
18. Fujihashi, K., J. R. McGhee, M. Kweon, M. D. Cooper, S. Tonegawa, I. Takahashi, T. Hiroi, J. Mestecky, and H. Kiyono. 1996. γ/δ T cell-deficient mice have impaired mucosal immunoglobulin A responses. J. Exp. Med. 183: 1929.
19. mac239. J. Virol. 71:1911.
20. Lohman, B. L., M. B. McChesney, C. J. Miller, E. McGowan, S. M. Joye, K. K. A. Van Rompay, E. Reay, L. Antipa, N. C. Pedersen, and M. L. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68: 7021.
21. Lohman, B. L., C. J. Miller, and M. B. McChesney. 1995. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155:5855.
22. Taswell, C. 1981. Limiting dilution analysis for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
23. Miller, C. J., N. J. Alexander, P. Vogel, J. Anderson, and P. A. Marx. 1992. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21:64.
24. Spira, A. I., P. A. Marx, B. K. Patterson, J. Mahoney, R. A. Koup, S. M. Wolinsky, and D. D. Ho. 1996. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183:215.
25. Marthas, M. L., C. J. Miller, B. Banapour, S. Sutjipto, J. Torten, B. L. Lohman, R. E. Unger, H. Kiyono, J. R. McGhee, P. A. Marx, and N. C. Pedersen. 1992. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J. Med. Primatol. 21:99.
26. Kiyono, H., J. Bienenstock, J. R. McGhee, and P. B. Ernst. 1992. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development. Reg. Immunol. 4:54.
27. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldrigde, M. Hirasawa, and H. Kiyono. 1992. The common mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75.
28. Anderson, D. L., and C. D. Tsoukas. 1989. Cholera toxin inhibits resting human T cell activation via cAMP-independent pathway. J. Immunol. 143:3648.
29. Imboden, J. B., D. M. Shoback, G. Pattison, and J. D. Stobo. 1986. Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol triphosphate and cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA 83:5673.
30. McGhee, J. R., J. Mestecky, C. O. Elson, and H. Kiyono. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:175.
31. Briére, F., J.-M. Bridon, D. Chevet, G. Souillet, F. Bienvenu, C. Guret, H. Martinez-Valdez, and J. Banchereau. 1994. Interleukin 10 induces B lymphocytes from IgA-deficient patients. J. Clin. Invest. 94:97.
32. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
33. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707.
34. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
35. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
36. Snider, D. P., J. S. Marshall, M. H. Perdue, and H. Liang. 1994. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 153:647.
37. Porgador, A., H. F. Staats, B. Faiola, E. Gilboa, and T. J. Palker. 1997. Nasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J. Immunol. 158:834.
38. Spangler, B. D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622.